We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

517 hedge funds and large institutions have $11.9B invested in Quest Diagnostics in 2014 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 180 increasing their positions, 172 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more first-time investments, than exits

New positions opened: 83 | Existing positions closed: 43

88% more funds holding in top 10

Funds holding in top 10: 8 → 15 (+7)

35% more capital invested

Capital invested by funds: $8.81B → $11.9B (+$3.1B)

7% more funds holding

Funds holding: 485 → 517 (+32)

5% more repeat investments, than reductions

Existing positions increased: 180 | Existing positions reduced: 172

1.55% less ownership

Funds ownership: 101.82% → 100.27% (-1.5%)

75% less call options, than puts

Call options by funds: $62.4M | Put options by funds: $250M

Holders
517
Holders Change
+32
Holders Change %
+6.6%
% of All Funds
13.79%
Holding in Top 10
15
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+87.5%
% of All Funds
0.4%
New
83
Increased
180
Reduced
172
Closed
43
Calls
$62.4M
Puts
$250M
Net Calls
-$188M
Net Calls Change
-$104M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$149M
2
Ninety One (UK)
Ninety One (UK)
United Kingdom
+$111M
3
Capital International Investors
Capital International Investors
California
+$88M
4
Millennium Management
Millennium Management
New York
+$76.4M
5
Renaissance Technologies
Renaissance Technologies
New York
+$53.7M

Top Sellers

1
Bank of America
Bank of America
North Carolina
-$283M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$127M
3
T
TOBAM
France
-$109M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$106M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$53.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
HCC
501
Hirtle Callaghan & Co
Pennsylvania
$8K – – –
EWM
502
Evercore Wealth Management
New York
$7K – – –
LWM
503
Lenox Wealth Management
Ohio
$7K – – –
JIC
504
Joel Isaacson & Co
New York
$7K +$63 +1 +1%
FAM
505
Formidable Asset Management
Ohio
$6K – – –
S
506
SignatureFD
Georgia
$6K – – –
TFO
507
Tarbox Family Office
California
$6K – – –
ASN
508
Advisory Services Network
Georgia
$6K +$5.43K +86 New
IC
509
Intersect Capital
California
$5K +$4.42K +70 New
GGPS
510
Gary Goldberg Planning Services
New York
$4K -$14.7K -233 -80%
HR
511
Howe & Rusling
New York
$4K – – –
GAM
512
Gemmer Asset Management
California
$3K – – –
GI
513
Gradient Investments
Minnesota
$3K +$2.59K +41 New
CG
514
Colony Group
Massachusetts
$3K +$2.9K +46 New
TDC
515
Thompson Davis & Co
Virginia
$2K +$883 +14 +100%
CPIG
516
Chicago Partners Investment Group
Illinois
$2K +$1.51K +24 New
CAW
517
Cornerstone Advisors (Washington)
Washington
$2K +$1.64K +26 New
PRS
518
Pinkerton Retirement Specialists
Idaho
$1K +$15.1K +240 New
BRWA
519
B. Riley Wealth Advisors
Florida
$41 +$38.4K +608 New
ACM
520
Addison Clark Management
Connecticut
– -$41M -675,264 Closed
Pzena Investment Management
521
Pzena Investment Management
New York
– -$26.1M -429,700 Closed
ICAP
522
Independence Capital Asset Partners
Colorado
– -$11.4M -187,898 Closed
SI
523
Sentry Investments
Ontario, Canada
– -$8.09M -133,300 Closed
N
524
Natixis
France
– -$5.51M -90,809 Closed
EAM
525
EverPoint Asset Management
Connecticut
– -$5.46M -90,000 Closed
19 20
21
22 23

DGX Hedge Fund Activity: Q4 2014 in Review

517 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q4 2014, worth a combined $11.9B — up 35% from $8.81B a quarter earlier.

Buyers outnumbered sellers: 83 funds opened new DGX positions and 43 closed out — a net gain of 40 holders — while 180 added to existing stakes and 172 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $149M. The largest seller was Bank of America, cutting an estimated $283M.

  • 517 institutional investors held Quest Diagnostics (DGX) as of Q4 2014, up from 485 in Q3 2014.
  • Funds reported $11.9B of Quest Diagnostics stock for Q4 2014, up 35% quarter-over-quarter.
  • 83 funds opened new Quest Diagnostics positions in Q4 2014 and 43 closed out, a net change of +40 holders.
  • The largest Quest Diagnostics buyer in Q4 2014 was Citadel Advisors, an estimated $149M added.
  • The largest Quest Diagnostics seller in Q4 2014 was Bank of America, an estimated $283M sold.

Based on aggregated 13F filings for Q4 2014.